Top Quality Pharmaceutical Powder Raloxifene Hydrochloride CAS: 82640-04-8
- الصانع: Dewael
- الفحص المنتج: 99%+
- مظهر خارجي:light yellow powder
- مكان المنشأ: الصين
- شهادة: SGS,ISO9001، GMP
- أقل كمية ممكن طلبها: 10ز
- تفاصيل التعبئة: 1 كجم/كيس رقائق,25kg/drum or as your requirements
- موعد التسليم: في غضون 12 ساعة بعد تلقي دفعتك
- شروط الدفع: الاتحاد الغربي, موني جرام,بيتكوين,التحويل المصرفي
- الشحن: EMS,DHL,فيديكس,يو بي إس,TNT وهلم جرا.
- سياسات: إعادة شحن سياسة
- قدرة العرض: 500-600كغم / شهر
Top Quality Pharmaceutical Powder Raloxifene Hydrochloride CAS: 82640-04-8
تفاصيل:
اسم:raloxifene hcl, رالوكسيفين هيدروكلوريد
CAS No.:82640-04-8
MF:C28H28ClNO4S
استعمال:antineoplastic
مظهر خارجي:light yellow powder
تخصيص:
| اسم المنتج: | رالوكسيفين هيدروكلوريد |
| CAS: | 82640-04-8 |
| MF: | C28H28ClNO4S |
| MW: | 510.04 |
| فئات المنتجات: | Active Pharmaceutical Ingredients;Raloxifene;Intracellular receptor;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Pharmaceutical intermediate |
| Mol File: | 82640-04-8.mol |
| mp | 250-253° C |
| storage temp. | -20°C Freezer |
| solubility | DMSO: 28 mg/mL, soluble |
| form | solid |
| color | light yellow |
| CAS DataBase Reference | 82640-04-8(CAS DataBase Reference) |
| Chemical Properties | Light-Yellow Solid |
| استعمال | A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic. |
Raloxifene Hydrochloride Description:
Raloxifene (marketed as Evista) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.
Raloxifene Hydrochloride Application:
Because of Raloxifene’s greater differences in its selectivity of Estrogen agonism and antagonism in different tissues in the body, there is ongoing investigation of its application in other diseases, including prostate cancer, acromegaly, uterine cancer, cardiovascular disease, and breast cancer.
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate.
Raloxifene is used to prevent and treat bone loss (هشاشة العظام) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.
Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.
———————————————————————————————————————————————————————————————————————————————————————-
اتصل الآن
التعليقات
لا توجد توصيات بعد.